• Employers must follow the recommended schedule for reviewing written programs, conducting blood level testing, and performing medical examinations and consultations.

Employers must:

• Review written programs every six months.
• Perform blood lead and zinc protoporphyrin level sampling and analysis availability:
  • Every six months to each employee exposed above the action level for more than 30 days per year;
  • Every two months for each employee whose last blood sampling and analysis indicated a blood lead level at or above 40 μg/100 g of whole blood (and continue this frequency until two consecutive blood samples and analyses indicate a blood lead level below 40 μg/100 g of whole blood); and
  • Monthly during the removal period of each employee removed from exposure to lead due to an elevated blood lead level.
• Perform follow-up blood sampling tests availability whenever the results of a blood lead level test indicate that an employee’s blood lead level is at or above the numerical criterion for medical removal (at or above 60 μg/100 g), and provide a second (follow-up) blood sampling test within two weeks after the employer receives the results of the first blood sampling test.
• Perform medical examinations and consultations availability for each employee exposed above the action level for more than 30 days per year:
  • At least annually for each employee for whom a blood sampling test conducted at any time during the preceding 12 months indicated a blood lead level at or above 40 μg/100 g.
  • As medically appropriate for each employee either removed from exposure to lead due to a risk of sustaining material impairment to health, or otherwise limited pursuant to a final medical determination.